Retrospective Data Study of HCV [hepatitis C virus] Genotype 1 Patients in the UK [United Kingdom] Treated With ViraferonPeg [peginterferon alfa-2b] and Rebetol [ribavirin].

Trial Profile

Retrospective Data Study of HCV [hepatitis C virus] Genotype 1 Patients in the UK [United Kingdom] Treated With ViraferonPeg [peginterferon alfa-2b] and Rebetol [ribavirin].

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2013

At a glance

  • Drugs Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 04 Jun 2010 Actual number of patients (442) added as reported by ClinicalTrials.gov.
    • 04 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Feb 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top